Description

Thymosin Alpha-1, an  Advanced Immunomodulatory Peptide for Cellular & Immune Research Applications, is a synthetic version of a naturally occurring thymic peptide involved in immune regulation.

It primarily acts as an immune modulator, meaning it enhances or balances immune responses rather than simply stimulating them indiscriminately.

Overview

Thymosin Alpha-1 (TA1) is a synthetic analogue of a naturally occurring thymic peptide investigated for its role in immune modulation, T-cell differentiation, and cytokine signalling. It is widely studied in laboratory environments for its effects on adaptive immune function, inflammatory pathway regulation, and host-response mechanisms.

Click to access Protocols-3.pdf

Key Research Attributes

• Boosts natural killer (NK) cell activity and supports early defence against viral and malignant cells.
• Immune System Modulation – Investigated for effects on T-cell maturation and immune signalling pathways.
• Cytokine Regulation – Explored for modulation of inflammatory and anti-inflammatory cytokine expression.
• Innate & Adaptive Immune Research – Supports investigation into coordinated immune response mechanisms.
• Cellular Defence Pathways – Studied for enhancement of antigen presentation and immune recognition processes.
• Inflammatory Stress Applications – Useful in modelling immune resilience and inflammatory signalling.
• Enhances T-cell maturation and differentiation – Supports development and function of CD4⁺ and CD8⁺ T lymphocytes.
• Improves antigen presentation – Enhances dendritic cell activity and their ability to activate adaptive immunity.
• Up regulates toll-like receptors (TLRs) – Strengthens innate immune recognition of pathogens.
• Increases interferon production – Promotes antiviral signalling pathways.

Applications in Scientific Research

• Immune signalling and cytokine pathway analysis
• T-cell differentiation and thymic peptide research
• Inflammatory response and immune modulation studies
• Host defence and adaptive immunity investigations
• Integrated immune resilience pathway modelling
• Chronic viral infections (e.g., hepatitis B and C in some regions)
• Sepsis and severe infections (investigational use)
• Cancer immunotherapy adjunct
• COVID-19 immune modulation (research settings)
• Vaccine response enhancement (studied in elderly population)

Thymosin Alpha-1 helps the immune system:

• Recognise threats more effectively

• Activate T-cells properly

• Improve antiviral and anti-tumor signalling

• Restore balance when immunity is suppressed

Format & Storage

Form: Lyophilised peptide powder Compound: Thymosin Alpha-1 (TA1) Purity: 99%

Storage: Store at -20°C

Reconstitution: Use bacteriostatic water for preparation.